Journal Article

Growth Hormone Receptor (GH)-Expressing Carcinoid Tumors after Recombinant Human GH Therapy for Human Immunodeficiency Virus-Related Lipodystrophy

Liron Pantanowitz, Tomás García-Caballero and Bruce J. Dezube

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 36, issue 3, pages 370-372
Published in print February 2003 | ISSN: 1058-4838
Published online February 2003 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/345992
Growth Hormone Receptor (GH)-Expressing Carcinoid Tumors after Recombinant Human GH Therapy for Human Immunodeficiency Virus-Related Lipodystrophy

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

We describe a patient who had growth hormone receptor-expressing carcinoid tumors develop in the distal colon and rectum after he received recombinant human growth hormone therapy for human immunodeficiency virus-related lipodystrophy. This case report serves as a cautionary note regarding the use of potentially oncogenic recombinant human growth hormone therapy to treat human immunodeficiency virus-positive persons.

Journal Article.  1851 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.